Preferential induction of cross-group influenza A hemagglutinin stem–specific memory B cells after H7N9 immunization in humans

Science Immunology

Volumn 2, Issue 13, 2017, Pages

  Andrews, Sarah F ^a   Gordon Joyce, M ^a   Chambers, Michael J ^a   Gillespie, Rebecca A ^a   Kanekiyo, Masaru ^a   Leung, Kwanyee ^a   Yang, Eun Sung ^a   Tsybovsky, Yaroslav ^b   Wheatley, Adam K ^c   Crank, Michelle C ^a   Boyington, Jeffrey C ^a   Prabhakaran, Madhu S ^a   Narpala, Sandeep R ^a   Chen, Xuejun ^a   Bailer, Robert T ^a   Chen, Grace ^a   Coates, Emily ^a   Kwong, Peter D ^a   Koup, Richard A ^a   Mascola, John R ^a   Graham, Barney S ^a   Ledgerwood, Julie E ^a   McDermott, Adrian B ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054983006     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aan2676     Document Type: Article

References (53)

1. D. Corti, J. Voss, S. J. Gamblin, G. Codoni, A. Macagno, D. Jarrossay, S. G. Vachieri, D. Pinna, A. Minola, F. Vanzetta, C. Silacci, B. M. Fernandez-Rodriguez, G. Agatic, S. Bianchi, I. Giacchetto-Sasselli, L. Calder, F. Sallusto, P. Collins, L. F. Haire, N. Temperton, J. P. M. Langedijk, J. J. Skehel, A. Lanzavecchia, A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850–856 (2011).
2. C. Dreyfus, N. S. Laursen, T. Kwaks, D. Zuijdgeest, R. Khayat, D. C. Ekiert, J. H. Lee, Z. Metlagel, M. V. Bujny, M. Jongeneelen, R. van der Vlugt, M. Lamrani, H. J. W. M. Korse, E. Geelen, Ö. Sahin, M. Sieuwerts, J. P. J. Brakenhoff, R. Vogels, O. T. W. Li, L. L. M. Poon, M. Peiris, W. Koudstaal, A. B. Ward, I. A. Wilson, J. Goudsmit, R. H. E. Friesen, Highly conserved protective epitopes on influenza B viruses. Science 337, 1343–1348 (2012).
3. + memory B cells. PLOS ONE 3, e3942 (2008).
4. Y. Okuno, Y. Isegawa, F. Sasao, S. Ueda, A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67, 2552–2558 (1993).
5. J. Sui, W. C. Hwang, S. Perez, G. Wei, D. Aird, L.-M. Chen, E. Santelli, B. Stec, G. Cadwell, M. Ali, H. Wan, A. Murakami, A. Yammanuru, T. Han, N. J. Cox, L. A. Bankston, R. O. Donis, R. C. Liddington, W. A. Marasco, Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265–273 (2009).
6. H. M. Yassine, J. C. Boyington, P. M. McTamney, C.-J. Wei, M. Kanekiyo, W.-P. Kong, J. R. Gallagher, L. Wang, Y. Zhang, M. G. Joyce, D. Lingwood, S. M. Moin, H. Andersen, Y. Okuno, S. S. Rao, A. K. Harris, P. D. Kwong, J. R. Mascola, G. J. Nabel, B. S. Graham, Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat. Med. 21, 1065–1070 (2015).
7. A. Impagliazzo, F. Milder, H. Kuipers, M. V. Wagner, X. Zhu, R. M. B. Hoffman, R. van Meersbergen, J. Huizingh, P. Wanningen, J. Verspuij, M. de Man, Z. Ding, A. Apetri, B. Kükrer, E. Sneekes-Vriese, D. Tomkiewicz, N. S. Laursen, P. S. Lee, A. Zakrzewska, L. Dekking, J. Tolboom, L. Tettero, S. van Meerten, W. Yu, W. Koudstaal, J. Goudsmit, A. B. Ward, W. Meijberg, I. A. Wilson, K. Radošević, A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349, 1301–1306 (2015).
8. T. J. Wohlbold, R. Nachbagauer, I. Margine, G. S. Tan, A. Hirsh, F. Krammer, Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses. Vaccine 33, 3314–3321 (2015).
9. R. Nachbagauer, M. S. Miller, R. Hai, A. B. Ryder, J. K. Rose, P. Palese, A. García-Sastre, F. Krammer, R. A. Albrecht, Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets. J. Virol. 90, 3268–3273 (2016).
10. M. Klausberger, R. Tscheliessnig, S. Neff, R. Nachbagauer, T. J. Wohlbold, M. Wilde, D. Palmberger, F. Krammer, A. Jungbauer, R. Grabherr, Globular head-displayed conserved influenza H1 hemagglutinin stalk epitopes confer protection against heterologous H1N1 virus. PLOS ONE 11, e0153579 (2016).
11. S. A. Valkenburg, V. V. A. Mallajosyula, O. T. W. Li, A. W. H. Chin, G. Carnell, N. Temperton, R. Varadarajan, L. L. M. Poon, Stalking influenza by vaccination with pre-fusion headless HA mini-stem. Sci. Rep. 6, 22666 (2016).
12. J. Wrammert, D. Koutsonanos, G.-M. Li, S. Edupuganti, J. Sui, M. Morrissey, M. McCausland, I. Skountzou, M. Hornig, W. I. Lipkin, A. Mehta, B. Razavi, C. Del Rio, N.-Y. Zheng, J.-H. Lee, M. Huang, Z. Ali, K. Kaur, S. Andrews, R. R. Amara, Y. Wang, S. R. Das, C. D. O’Donnell, J. W. Yewdell, K. Subbarao, W. A. Marasco, M. J. Mulligan, R. Compans, R. Ahmed, P. C. Wilson, Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181–193 (2011).
13. C. A. Thomson, Y. Wang, L. M. Jackson, M. Olson, W. Wang, A. Liavonchanka, L. Keleta, V. Silva, S. Diederich, R. B. Jones, J. Gubbay, J. Pasick, M. Petric, F. Jean, V. G. Allen, E. G. Brown, J. M. Rini, J. W. Schrader, Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem. Front. Immunol. 3, 87 (2012).
14. G.-M. Li, C. Chiu, J. Wrammert, M. McCausland, S. F. Andrews, N.-Y. Zheng, J.-H. Lee, M. Huang, X. Qu, S. Edupuganti, M. Mulligan, S. R. Das, J. W. Yewdell, A. K. Mehta, P. C. Wilson, R. Ahmed, Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. U.S.A. 109, 9047–9052 (2012).
15. A. K. Wheatley, J. R. R. Whittle, D. Lingwood, M. Kanekiyo, H. M. Yassine, S. S. Ma, S. R. Narpala, M. S. Prabhakaran, R. A. Matus-Nicodemos, R. T. Bailer, G. J. Nabel, B. S. Graham, J. E. Ledgerwood, R. A. Koup, A. B. McDermott, H5N1 vaccine-elicited memory B cells are genetically constrained by the IGHV locus in the recognition of a neutralizing epitope in the hemagglutinin stem. J. Immunol. 195, 602–610 (2015).
16. J. R. R. Whittle, A. K. Wheatley, L. Wu, D. Lingwood, M. Kanekiyo, S. S. Ma, S. R. Narpala, H. M. Yassine, G. M. Frank, J. W. Yewdell, J. E. Ledgerwood, C.-J. Wei, A. B. McDermott, B. S. Graham, R. A. Koup, G. J. Nabel, Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. J. Virol. 88, 4047–4057 (2014).
17. D. C. Ekiert, G. Bhabha, M.-A. Elsliger, R. H. E. Friesen, M. Jongeneelen, M. Throsby, J. Goudsmit, I. A. Wilson, Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246–251 (2009).
18. L. Pappas, M. Foglierini, L. Piccoli, N. L. Kallewaard, F. Turrini, C. Silacci, B. Fernandez-Rodriguez, G. Agatic, I. Giacchetto-Sasselli, G. Pellicciotta, F. Sallusto, Q. Zhu, E. Vicenzi, D. Corti, A. Lanzavecchia, Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516, 418–422 (2014).
19. D. Lingwood, P. M. McTamney, H. M. Yassine, J. R. R. Whittle, X. Guo, J. C. Boyington, C.-J. Wei, G. J. Nabel, Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489, 566–570 (2012).
20. Y. Avnir, A. S. Tallarico, Q. Zhu, A. S. Bennett, G. Connelly, J. Sheehan, J. Sui, A. Fahmy, C.-Y. Huang, G. Cadwell, L. A. Bankston, A. T. McGuire, L. Stamatatos, G. Wagner, R. C. Liddington, W. A. Marasco, Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. PLOS Pathog. 10, e1004103 (2014).
21. D. C. Ekiert, R. H. E. Friesen, G. Bhabha, T. Kwaks, M. Jongeneelen, W. Yu, C. Ophorst, F. Cox, H. J. W. M. Korse, B. Brandenburg, R. Vogels, J. P. J. Brakenhoff, R. Kompier, M. H. Koldijk, L. A. H. M. Cornelissen, L. L. M. Poon, M. Peiris, W. Koudstaal, I. A. Wilson, J. Goudsmit, A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843–850 (2011).
22. C. J. Henry Dunand, P. E. Leon, K. Kaur, G. S. Tan, N.-Y. Zheng, S. Andrews, M. Huang, X. Qu, Y. Huang, M. Salgado-Ferrer, I. Y. Ho, W. Taylor, R. Hai, J. Wrammert, R. Ahmed, A. García-Sastre, P. Palese, F. Krammer, P. C. Wilson, Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. J. Clin. Invest. 125, 1255–1268 (2015).
23. Y. Wu, M. Cho, D. Shore, M. Song, J. Choi, T. Jiang, Y.-Q. Deng, M. Bourgeois, L. Almli, H. Yang, L.-M. Chen, Y. Shi, J. Qi, A. Li, K. S. Yi, M. Chang, J. S. Bae, H. Lee, J. Shin, J. Stevens, S. Hong, C.-F. Qin, G. F. Gao, S. J. Chang, R. O. Donis, A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nat. Commun. 6, 7708 (2015).
24. M. G. Joyce, A. K. Wheatley, P. V. Thomas, G.-Y. Chuang, C. Soto, R. T. Bailer, A. Druz, I. S. Georgiev, R. A. Gillespie, M. Kanekiyo, W.-P. Kong, K. Leung, S. N. Narpala, M. S. Prabhakaran, E. S. Yang, B. Zhang, Y. Zhang, M. Asokan, J. C. Boyington, T. Bylund, S. Darko, C. R. Lees, A. Ransier, C.-H. Shen, L. Wang, J. R. Whittle, X. Wu, H. M. Yassine, C. Santos, Y. Matsuoka, Y. Tsybovsky, U. Baxa; NISC Comparative Sequencing Program, J. C. Mullikin, K. Subbarao, D. C. Douek, B. S. Graham, R. A. Koup, J. E. Ledgerwood, M. Roederer, L. Shapiro, P. D. Kwong, J. R. Mascola, A. B. McDermott, Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses. Cell 166, 609–623 (2016).
25. N. L. Kallewaard, D. Corti, P. J. Collins, U. Neu, J. M. McAuliffe, E. Benjamin, L. Wachter-Rosati, F. J. Palmer-Hill, A. Q. Yuan, P. A. Walker, M. K. Vorlaender, S. Bianchi, B. Guarino, A. De Marco, F. Vanzetta, G. Agatic, M. Foglierini, D. Pinna, B. Fernandez-Rodriguez, A. Fruehwirth, C. Silacci, R. W. Ogrodowicz, S. R. Martin, F. Sallusto, J. A. Suzich, A. Lanzavecchia, Q. Zhu, S. J. Gamblin, J. J. Skehel, Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166, 596–608 (2016).
26. J. E. Ledgerwood, K. Zephir, Z. Hu, C.-J. Wei, L. Chang, M. E. Enama, C. S. Hendel, S. Sitar, R. T. Bailer, R. A. Koup, J. R. Mascola, G. J. Nabel, B. S. Graham; VRC 310 Study Team, Prime-boost interval matters: A randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect. J. Infect. Dis. 208, 418–422 (2013).
27. A. D. DeZure, E. E. Coates, Z. Hu, G. V. Yamshchikov, K. L. Zephir, M. E. Enama, S. H. Plummer, I. J. Gordon, F. Kaltovich, S. Andrews, A. McDermott, M. C. Crank, R. A. Koup, R. M. Schwartz, R. T. Bailer, X. Sun, J. R. Mascola, T. M. Tumpey, B. S. Graham, J. E. Ledgerwood, An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial. npj Vaccines 2, 15 (2017).
28. D. J. DiLillo, G. S. Tan, P. Palese, J. V. Ravetch, Broadly neutralizing hemagglutinin stalk–specific antibodies require FcR interactions for protection against influenza virus in vivo. Nat. Med. 20, 143–151 (2014).
29. D. J. DiLillo, P. Palese, P. C. Wilson, J. V. Ravetch, Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J. Clin. Invest. 126, 605–610 (2016).
30. S. F. Andrews, Y. Huang, K. Kaur, L. I. Popova, I. Y. Ho, N. T. Pauli, C. J. Henry Dunand, W. M. Taylor, S. Lim, M. Huang, X. Qu, J.-H. Lee, M. Salgado-Ferrer, F. Krammer, P. Palese, J. Wrammert, R. Ahmed, P. C. Wilson, Immune history profoundly affects broadly protective B cell responses to influenza. Sci. Transl. Med. 7, 316ra192 (2015).
31. C. J. Henry Dunand, P. E. Leon, M. Huang, A. Choi, V. Chromikova, I. Y. Ho, G. S. Tan, J. Cruz, A. Hirsh, N.-Y. Zheng, C. E. Mullarkey, F. A. Ennis, M. Terajima, J. J. Treanor, D. J. Topham, K. Subbarao, P. Palese, F. Krammer, P. C. Wilson, Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection. Cell Host Microbe 19, 800–813 (2016).
32. N. J. Thornburg, H. Zhang, S. Bangaru, G. Sapparapu, N. Kose, R. M. Lampley, R. G. Bombardi, Y. Yu, S. Graham, A. Branchizio, S. M. Yoder, M. T. Rock, C. B. Creech, K. M. Edwards, D. Lee, S. Li, I. A. Wilson, A. García-Sastre, R. A. Albrecht, J. E. Crowe Jr., H7N9 influenza virus neutralizing antibodies that possess few somatic mutations. J. Clin. Invest. 126, 1482–1494 (2016).
33. G. Nakamura, N. Chai, S. Park, N. Chiang, Z. Lin, H. Chiu, R. Fong, D. Yan, J. Kim, J. Zhang, W. P. Lee, A. Estevez, M. Coons, M. Xu, P. Lupardus, M. Balazs, L. R. Swem, An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies. Cell Host Microbe 14, 93–103 (2013).
34. A. G. Schmidt, M. D. Therkelsen, S. Stewart, T. B. Kepler, H.-X. Liao, M. A. Moody, B. F. Haynes, S. C. Harrison, Viral receptor-binding site antibodies with diverse germline origins. Cell 161, 1026–1034 (2015).
35. J. Lessler, S. Riley, J. M. Read, S. Wang, H. Zhu, G. J. D. Smith, Y. Guan, C. Q. Jiang, D. A. T. Cummings, Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLOS Pathog. 8, e1002802 (2012).
36. M. S. Miller, T. J. Gardner, F. Krammer, L. C. Aguado, D. Tortorella, C. F. Basler, P. Palese, Neutralizing antibodies against previously encountered influenza virus strains increase over time: A longitudinal analysis. Sci. Transl. Med. 5, 198ra107 (2013).
37. K. M. Gostic, M. Ambrose, M. Worobey, J. O. Lloyd-Smith, Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science 354, 722–726 (2016).
38. B. Brandenburg, W. Koudstaal, J. Goudsmit, V. Klaren, C. Tang, M. V. Bujny, H. J. W. M. Korse, T. Kwaks, J. J. Otterstrom, J. Juraszek, A. M. van Oijen, R. Vogels, R. H. E. Friesen, Mechanisms of hemagglutinin targeted influenza virus neutralization. PLOS ONE 8, e80034 (2013).
39. J. E. Ledgerwood, C.-J. Wei, Z. Hu, I. J. Gordon, M. E. Enama, C. S. Hendel, P. M. McTamney, M. B. Pearce, H. M. Yassine, J. C. Boyington, R. Bailer, T. M. Tumpey, R. A. Koup, J. R. Mascola, G. J. Nabel, B. S. Graham; VRC 306 Study Team, DNA priming and influenza vaccine immunogenicity: Two phase 1 open label randomised clinical trials. Lancet Infect. Dis. 11, 916–924 (2011).
40. T. Tiller, E. Meffre, S. Yurasov, M. Tsuiji, M. C. Nussenzweig, H. Wardemann, Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112–124 (2008).
41. X. Brochet, M.-P. Lefranc, V. Giudicelli, IMGT/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503–W508 (2008).
42. E. Hoffmann, G. Neumann, Y. Kawaoka, G. Hobom, R. G. Webster, A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U.S.A. 97, 6108–6113 (2000).
43. W. H. Organization, Serological Diagnosis of Influenza by Microneutralization Assay, 2010. (World Health Organization, 2013), pp. 1–25.
44. D. N. Mastronarde, Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).
45. G. Tang, L. Peng, P. R. Baldwin, D. S. Mann, W. Jiang, I. Rees, S. J. Ludtke, EMAN2: An extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38–46 (2007).
46. S. H. W. Scheres, RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).
47. Z.-Y. Yang, C.-J. Wei, W.-P. Kong, L. Wu, L. Xu, D. F. Smith, G. J. Nabel, Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 317, 825–828 (2007).
48. L. Naldini, U. Blömer, F. H. Gage, D. Trono, I. M. Verma, Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382–11388 (1996).
49. Z. Otwinowski, W. Minor, Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
50. P. Emsley, B. Lohkamp, W. G. Scott, K. Cowtan, Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
51. P. D. Adams, P. V. Afonine, G. Bunkóczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L.-W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. Terwilliger, P. H. Zwart, PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
52. E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, UCSF Chimera—A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
53. S. Kumar, G. Stecher, K. Tamura, MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33, 1870–1874 (2016).